Publications, Pharmaceutical

An Eye on the Future of Preservative-Free Drops

In this article, Alexandra Ritter, Head of Regulatory Affairs and Combination Products, and Matthias Birkhoff, Vice-President Business Development, both at Aptar Pharma, discuss the value that Aptar Pharma’s regulatory support and services add to the filing process of a new eye care development, the challenges of administering a wider range of medications via topical eye drops and the benefits of preservative-free multidose ophthalmic drug-device combination products.

 

 

Download Publication
Author(s): Alexandra Ritter Matthias Birkhoff
15 Mar 2022

Learn more about our Ophthalmic Squeeze Dispenser

This Might Also Be of Your Interest

15 Mar 2022

An Eye on the Future of Preservative-Free Drops

Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
22 Dec 2021

The Go-To Drug Delivery Expert

Brochures, Pharmaceutical, Sustainability, Device Innovations, Brand Differentiation, Product Solutions

Read More
22 Dec 2021

End-To-End Support at Every Stage of Your Drug Development Journe...

Brochures, Pharmaceutical, Device Innovations, Brand Differentiation, Product Solutions

Read More
13 Dec 2021

Towards A New Standard of Care with Aptar Pharma’s Digital ...

Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Product Solutions

Read More
1 2 3 … 5

How Can We Help?

Back To Top